) [153]. This method is presently not scalable because it depends on highly-priced startup substrates which may be applied to provide psilocybin in much less expensive chemical synthesis methodologies. A methodology for de novo manufacture of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae,Microdosing Shrooms can also be sometimes